These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 26388691)

  • 1. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.
    Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H
    Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the biomaterials 3wt%-nanostrontium-hydroxyapatite-enhanced calcium phosphate cement (nanoSr-CPC) and nanoSr-CPC-incorporated simvastatin-loaded poly(lactic-co-glycolic-acid) microspheres in osteogenesis improvement: An explorative multi-phase experimental in vitro/vivo study.
    Masaeli R; Jafarzadeh Kashi TS; Dinarvand R; Rakhshan V; Shahoon H; Hooshmand B; Mashhadi Abbas F; Raz M; Rajabnejad A; Eslami H; Khoshroo K; Tahriri M; Tayebi L
    Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():171-83. PubMed ID: 27612702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-targeted delivery of simvastatin-loaded PEG-PLGA micelles conjugated with tetracycline for osteoporosis treatment.
    Xie Y; Liu C; Huang H; Huang J; Deng A; Zou P; Tan X
    Drug Deliv Transl Res; 2018 Oct; 8(5):1090-1102. PubMed ID: 30027372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of cationic polymeric nanoparticles as simvastatin carriers for enhancing the osteogenesis of bone marrow mesenchymal stem cells.
    Wang CZ; Fu YC; Jian SC; Wang YH; Liu PL; Ho ML; Wang CK
    J Colloid Interface Sci; 2014 Oct; 432():190-9. PubMed ID: 25086394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mZD7349 peptide-conjugated PLGA nanoparticles directed against VCAM-1 for targeted delivery of simvastatin to restore dysfunctional HUVECs.
    Imanparast F; Faramarzi MA; Vatannejad A; Paknejad M; Deiham B; Kobarfard F; Amani A; Doosti M
    Microvasc Res; 2017 Jul; 112():14-19. PubMed ID: 28161429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Complex of HSIM-loaded Polymeric Nanoparticles: Potential Carriers in Osteoporosis.
    Kaur M; Nagpal M; Grewal AK; Chauhan S; Dora CP; Singh TG
    Curr Drug Targets; 2023; 24(13):1066-1078. PubMed ID: 37718521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocompatibility and osteogenesis of calcium phosphate composite scaffolds containing simvastatin-loaded PLGA microspheres for bone tissue engineering.
    Zhang HX; Xiao GY; Wang X; Dong ZG; Ma ZY; Li L; Li YH; Pan X; Nie L
    J Biomed Mater Res A; 2015 Oct; 103(10):3250-8. PubMed ID: 25809455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation.
    Fu YC; Fu TF; Wang HJ; Lin CW; Lee GH; Wu SC; Wang CK
    Acta Biomater; 2014 Nov; 10(11):4583-4596. PubMed ID: 25050775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone-Targeting Nanoparticles of a Dendritic (Aspartic acid)
    Lin CW; Lee CY; Lin SY; Kang L; Fu YC; Chen CH; Wang CK
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
    Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
    Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
    Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC
    Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.
    Park JH; Cho HJ; Kim DD
    Int J Nanomedicine; 2017; 12():7453-7467. PubMed ID: 29066894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.
    Rawat P; Manglani K; Gupta S; Kalam A; Vohora D; Ahmad FJ; Talegaonkar S
    Pharm Res; 2015 Oct; 32(10):3149-58. PubMed ID: 25840949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.
    Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ
    Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.
    Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS
    Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.